All articles by Michelle Moore

Michelle Moore

Michelle Moore joined Medical Device Network in 2023 as a trainee healthcare reporter. With a background in medical science and economics, Michelle has experience working on medical and socioeconomic research projects. She is interested in molecular biology, personalised medicine and how artificial intelligence is changing the face of healthcare. Michelle holds a BSc in Biomedical Science and an MSc in Molecular Medicine, both from the University of Sheffield, as well as an MSc(Res) in Medicine and Economics from the University of St Andrews.

Cumulus teams up with the Universities of Bath and Bristol to develop Alzheimer’s tech

The research collaboration will focus on developing a new diagnostic test for AD.

Causaly secures $60 Million in series B funding

Causaly serves 12 of the top 20 pharmaceutical companies with technology that aims to expedite the drug discovery process.

Aerin reports positive results for VivAer

The study has demonstrated 90% patient improvement, sustained for two years.

Velico kick-starts trial for spray-dried plasma

Spray-dried plasma provides a potentially life-saving alternative to frozen plasma in time-sensitive cases like war zones.

Gustave Roussy and THERYQ partner to deliver new cancer radiotherapy technology

The new technology aims to reduce toxicity in healthy tissues without compromising the anti-cancer effects of treatment.

European Commission deals record €432m fine to Illumina over Grail

The Commission has issued approximately €432m to Illumina for breach of EU merger rules.

FDA issues recall for Megadyne’s MEGA 2000 and MEGA Soft products

The FDA has issued a Class I product recall of J&J’s Ethicon-manufactured electrodes due to serious risk of burns.

Quest launches direct-consumer genetic test

The test will use next-generation sequencing to assess the risk for inheritable health conditions.

Tetrous completes first surgeries using EnFix device

The Enfix RC is designed to enhance healing rather than simply reinforce the tendon.

Verici releases results for Clarava, a kidney transplant rejection test

The test will help inform clinicians of the likelihood of kidney rejection upon transplantation.